Skip to main content
Erschienen in: Wiener klinische Wochenschrift 7/2016

01.12.2016 | geriatrics: at crossroads of medicine

Heart failure management in the elderly – a public health challenge

verfasst von: Natasa Cvetinovic, Goran Loncar, Jerneja Farkas, MD, PhD

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 7/2016

Einloggen, um Zugang zu erhalten

Summary

Heart failure (HF) is a rapidly growing public health problem and the leading cause of morbidity, mortality, and hospitalization in populations > 65 years. The elderly HF patients have an increased prevalence of HF with preserved ejection fraction and comorbidities, may present with atypical symptoms and signs, have a higher risk for adverse drug reactions, and worse prognosis as compared with younger patients. Moreover, there is a lack of evidence-based therapies for this population because they are underrepresented in the clinical trials. The elderly are less likely to be evaluated by a cardiologist and to be treated in accordance with recommendations of the current HF guidelines. Although the treatment is improving, it is still suboptimal; therefore, HF in elderly patients requires mobilization of public health services and improvement of treatment strategies.
Literatur
1.
Zurück zum Zitat Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78.CrossRefPubMed Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–78.CrossRefPubMed
2.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.CrossRefPubMed
3.
Zurück zum Zitat Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–92.CrossRefPubMed Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015;17(9):884–92.CrossRefPubMed
4.
Zurück zum Zitat Sulaiman K, Panduranga P, Al-Zakwani I, et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail. 2015;17(4):374–84.CrossRefPubMed Sulaiman K, Panduranga P, Al-Zakwani I, et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE). Eur J Heart Fail. 2015;17(4):374–84.CrossRefPubMed
5.
Zurück zum Zitat Konishi M, Ishida J, Springer J, et al. Heart failure epidemiology and novel treatments in Japan: facts and numbers. Heart Fail. 2016;3:145–51. Konishi M, Ishida J, Springer J, et al. Heart failure epidemiology and novel treatments in Japan: facts and numbers. Heart Fail. 2016;3:145–51.
6.
Zurück zum Zitat Christ M, Störk S, Dörr M, et al. Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System. Eur J Hear Fail. 2016;18(8):1009–18.CrossRef Christ M, Störk S, Dörr M, et al. Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System. Eur J Hear Fail. 2016;18(8):1009–18.CrossRef
7.
Zurück zum Zitat Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(3):30–41.CrossRefPubMed Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(3):30–41.CrossRefPubMed
8.
Zurück zum Zitat Gabet A, Juillière Y, Lamarche-Vadel A, Vernay M, Olié V. National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000–2012. Eur J Heart Fail. 2015;17(6):583–90.CrossRefPubMed Gabet A, Juillière Y, Lamarche-Vadel A, Vernay M, Olié V. National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000–2012. Eur J Heart Fail. 2015;17(6):583–90.CrossRefPubMed
9.
Zurück zum Zitat Von der Heidt A, Ammenwerth E, Bauer K, et al. Herz Mobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria. Wien Klin Wochenschr. 2014;126(21–22):734–41.CrossRefPubMed Von der Heidt A, Ammenwerth E, Bauer K, et al. Herz Mobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria. Wien Klin Wochenschr. 2014;126(21–22):734–41.CrossRefPubMed
10.
Zurück zum Zitat Corrao G, Ghirardi A, Ibrahim B, Merlino L, Maggioni AP. Burden of new hospitalization for heart failure: a population-based investigation from Italy. Eur J Heart Fail. 2014;16(7):729–36.CrossRefPubMed Corrao G, Ghirardi A, Ibrahim B, Merlino L, Maggioni AP. Burden of new hospitalization for heart failure: a population-based investigation from Italy. Eur J Heart Fail. 2014;16(7):729–36.CrossRefPubMed
11.
Zurück zum Zitat Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: Preventing disease and death worldwide. Esc Heart Fail. 2014;1(1):4–25.CrossRef Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: Preventing disease and death worldwide. Esc Heart Fail. 2014;1(1):4–25.CrossRef
12.
Zurück zum Zitat Omersa D, Farkas J, Erzen I, Lainscak M. National trends in heart failure hospitalization rates in Slovenia 2004–2012. Eur J Heart Fail. 2016; . doi:10.1002/ejhf.617.PubMed Omersa D, Farkas J, Erzen I, Lainscak M. National trends in heart failure hospitalization rates in Slovenia 2004–2012. Eur J Heart Fail. 2016; . doi:10.​1002/​ejhf.​617.PubMed
13.
Zurück zum Zitat Cowie MR, Anker SD, Cleland JG, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. Esc Hear Fail. 2014;1(2):110–45.CrossRef Cowie MR, Anker SD, Cleland JG, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. Esc Hear Fail. 2014;1(2):110–45.CrossRef
14.
Zurück zum Zitat Van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–52.CrossRefPubMed Van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail. 2016;18(3):242–52.CrossRefPubMed
15.
Zurück zum Zitat Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068–72.CrossRefPubMed Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068–72.CrossRefPubMed
16.
Zurück zum Zitat Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O’Connor CM. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail. 2013;15(7):717–23.CrossRefPubMedPubMedCentral Lazzarini V, Mentz RJ, Fiuzat M, Metra M, O’Connor CM. Heart failure in elderly patients: distinctive features and unresolved issues. Eur J Heart Fail. 2013;15(7):717–23.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Lainscak M, Letonja M, Kovacic D, et al. General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011. Arch Med Sci. 2014;10(2):355–60.CrossRefPubMedPubMedCentral Lainscak M, Letonja M, Kovacic D, et al. General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011. Arch Med Sci. 2014;10(2):355–60.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Störk S, Kavoliuniene A, Vinereanu D, et al. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J Heart Fail. 2016;18(1):66–70.CrossRefPubMed Störk S, Kavoliuniene A, Vinereanu D, et al. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J Heart Fail. 2016;18(1):66–70.CrossRefPubMed
19.
Zurück zum Zitat SHAPE Study Group, Remme WJ, McMurray JJ, Hobbs FD, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J. 2008;29(14):1739–52.CrossRef SHAPE Study Group, Remme WJ, McMurray JJ, Hobbs FD, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J. 2008;29(14):1739–52.CrossRef
20.
Zurück zum Zitat Remme WJ, McMurray JJ, Rauch B, et al. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J. 2005;26(22):2413–21.CrossRefPubMed Remme WJ, McMurray JJ, Rauch B, et al. Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J. 2005;26(22):2413–21.CrossRefPubMed
21.
Zurück zum Zitat Vitale C, Rosano G, Fini M. Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment. Wien Klin Wochenschr. 2016; doi:10.1007/s00508-016-1082-x. Vitale C, Rosano G, Fini M. Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment. Wien Klin Wochenschr. 2016; doi:10.​1007/​s00508-016-1082-x.
22.
Zurück zum Zitat Montero-Perez-Barquero M, Flather M, Roughton M, et al. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial. Eur J Heart Fail. 2014;16(9):1009–15.CrossRefPubMed Montero-Perez-Barquero M, Flather M, Roughton M, et al. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial. Eur J Heart Fail. 2014;16(9):1009–15.CrossRefPubMed
23.
Zurück zum Zitat Metra M, Mentz RJ, Chiswell K, et al. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015;17(1):109–18.CrossRefPubMed Metra M, Mentz RJ, Chiswell K, et al. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015;17(1):109–18.CrossRefPubMed
24.
Zurück zum Zitat Teixeira A, Parenica J, Park JJ, et al. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail. 2015;17(11):1114–23.CrossRefPubMed Teixeira A, Parenica J, Park JJ, et al. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J Heart Fail. 2015;17(11):1114–23.CrossRefPubMed
25.
Zurück zum Zitat Lund LH, Benson L, Ståhlberg M, et al. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14713 patients in the Swedish Heart Failure Registry. Eur J Heart Fail. 2014;16(10):1073–81.CrossRefPubMed Lund LH, Benson L, Ståhlberg M, et al. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14713 patients in the Swedish Heart Failure Registry. Eur J Heart Fail. 2014;16(10):1073–81.CrossRefPubMed
26.
Zurück zum Zitat Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18(7):869–75.CrossRefPubMed Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18(7):869–75.CrossRefPubMed
27.
Zurück zum Zitat Jugdutt BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010;15(5):401–5.CrossRefPubMed Jugdutt BI. Aging and heart failure: changing demographics and implications for therapy in the elderly. Heart Fail Rev. 2010;15(5):401–5.CrossRefPubMed
28.
Zurück zum Zitat Abete P, Testa G, Della-Morte D, et al. Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev. 2013;18(4):529–51.CrossRefPubMed Abete P, Testa G, Della-Morte D, et al. Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev. 2013;18(4):529–51.CrossRefPubMed
29.
Zurück zum Zitat Sahle BW, Owen AJ, Krum H, Reid CM. Incidence of heart failure in 6083 elderly hypertensive patients: the second Australian National Blood Pressure Study (ANBP2). Eur J Heart Fail. 2016;18(1):38–45.CrossRefPubMed Sahle BW, Owen AJ, Krum H, Reid CM. Incidence of heart failure in 6083 elderly hypertensive patients: the second Australian National Blood Pressure Study (ANBP2). Eur J Heart Fail. 2016;18(1):38–45.CrossRefPubMed
30.
Zurück zum Zitat Salam AM, AlBinali HA, Al-Mulla AW, et al. Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991–2010). Int J Cardiol. 2013;168(2):975–80.CrossRefPubMed Salam AM, AlBinali HA, Al-Mulla AW, et al. Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991–2010). Int J Cardiol. 2013;168(2):975–80.CrossRefPubMed
31.
Zurück zum Zitat Mogensen UM, Ersboll M, Andersen M, et al. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Hear Fail. 2011;13:1216–23.CrossRef Mogensen UM, Ersboll M, Andersen M, et al. Clinical characteristics and major comorbidities in heart failure patients more than 85 years of age compared with younger age groups. Eur J Hear Fail. 2011;13:1216–23.CrossRef
32.
Zurück zum Zitat Jones SA. Ageing to arrhythmias: conundrums of connections in the ageing heart. J Pharm Pharmacol. 2006;58(12):1571–6.CrossRefPubMed Jones SA. Ageing to arrhythmias: conundrums of connections in the ageing heart. J Pharm Pharmacol. 2006;58(12):1571–6.CrossRefPubMed
33.
Zurück zum Zitat Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol. 2011;119:1–5.CrossRef Musso CG, Oreopoulos DG. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol. 2011;119:1–5.CrossRef
34.
Zurück zum Zitat Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Barsheshet A, Shotan A, Cohen E, et al. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail. 2010;12(8):833–40.CrossRefPubMed Barsheshet A, Shotan A, Cohen E, et al. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail. 2010;12(8):833–40.CrossRefPubMed
36.
Zurück zum Zitat Nieminen MS, Brutsaert D, Dickstein K, et al. Euro Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725–36.CrossRefPubMed Nieminen MS, Brutsaert D, Dickstein K, et al. Euro Heart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725–36.CrossRefPubMed
37.
Zurück zum Zitat Cermakova P, Lund LH, Fereshtehnejad SM, et al. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. Eur J Heart Fail. 2015;17(6):612–9.CrossRefPubMedPubMedCentral Cermakova P, Lund LH, Fereshtehnejad SM, et al. Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders. Eur J Heart Fail. 2015;17(6):612–9.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Ather S, Chan W, Bozkurt B, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59(11):998–1005.CrossRefPubMedPubMedCentral Ather S, Chan W, Bozkurt B, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59(11):998–1005.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Lainscak M, Hodoscek LM, Düngen HD, et al. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr. 2009;121(9–10):309–13.CrossRefPubMed Lainscak M, Hodoscek LM, Düngen HD, et al. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wien Klin Wochenschr. 2009;121(9–10):309–13.CrossRefPubMed
40.
Zurück zum Zitat Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226–33.CrossRefPubMed Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226–33.CrossRefPubMed
41.
Zurück zum Zitat Lainscak M, Cleland JG, Lenzen MJ, Follath F, Komajda M, Swedberg K. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail. 2007;9(3):292–9.CrossRefPubMed Lainscak M, Cleland JG, Lenzen MJ, Follath F, Komajda M, Swedberg K. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail. 2007;9(3):292–9.CrossRefPubMed
42.
Zurück zum Zitat Loncar G, Springer J, Anker M, Doehner W, Lainscak M. Cardiac cachexia: hic et nunc. “hic et nunc” – here and now. Int J Cardiol. 2015;201:e1–e12.CrossRefPubMed Loncar G, Springer J, Anker M, Doehner W, Lainscak M. Cardiac cachexia: hic et nunc. “hic et nunc” – here and now. Int J Cardiol. 2015;201:e1–e12.CrossRefPubMed
43.
Zurück zum Zitat Manzano L, Escobar C, Cleland JG, Flather M. Diagnosis of elderly patients with heart failure. Eur J Heart Fail. 2012;14(10):1097–103.CrossRefPubMed Manzano L, Escobar C, Cleland JG, Flather M. Diagnosis of elderly patients with heart failure. Eur J Heart Fail. 2012;14(10):1097–103.CrossRefPubMed
44.
Zurück zum Zitat Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A primary health care center study. Cardiology. 2007;107(4):226–32.CrossRefPubMed Olofsson M, Edebro D, Boman K. Are elderly patients with suspected HF misdiagnosed? A primary health care center study. Cardiology. 2007;107(4):226–32.CrossRefPubMed
45.
Zurück zum Zitat Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944–56.CrossRefPubMed Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944–56.CrossRefPubMed
46.
Zurück zum Zitat Loncar G, Omersa D, Cvetinovic N, Arandjelovic A, Lainscak M. Emerging biomarkers in heart failure and cardiac cachexia. Int J Mol Sci. 2014;15(12):23878–96.CrossRefPubMedPubMedCentral Loncar G, Omersa D, Cvetinovic N, Arandjelovic A, Lainscak M. Emerging biomarkers in heart failure and cardiac cachexia. Int J Mol Sci. 2014;15(12):23878–96.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Loncar G, Bozic B, Cvorovic V, et al. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. Endocrine. 2010;37(1):148–56.CrossRefPubMed Loncar G, Bozic B, Cvorovic V, et al. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. Endocrine. 2010;37(1):148–56.CrossRefPubMed
48.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69.CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69.CrossRefPubMed
49.
Zurück zum Zitat Bahrmann P, Bahrmann A, Hofner B, et al. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Eur Heart J Acute Cardiovasc Care. 2015;4(2):137–47.CrossRefPubMed Bahrmann P, Bahrmann A, Hofner B, et al. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department. Eur Heart J Acute Cardiovasc Care. 2015;4(2):137–47.CrossRefPubMed
50.
Zurück zum Zitat Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003;5(3):337–44.CrossRefPubMed Rutten FH, Grobbee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003;5(3):337–44.CrossRefPubMed
51.
Zurück zum Zitat Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162(15):1682–8.CrossRefPubMed Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162(15):1682–8.CrossRefPubMed
52.
Zurück zum Zitat Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215–25.CrossRefPubMed Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215–25.CrossRefPubMed
53.
Zurück zum Zitat Düngen HD, Apostolović S, Inkrot S, et al. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail. 2011;13(6):670–80.CrossRefPubMedPubMedCentral Düngen HD, Apostolović S, Inkrot S, et al. Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail. 2011;13(6):670–80.CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349(9054):747–52.CrossRefPubMed Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349(9054):747–52.CrossRefPubMed
55.
Zurück zum Zitat Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338–45.CrossRefPubMed Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338–45.CrossRefPubMed
56.
Zurück zum Zitat Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J. 2009;30(4):478–86.CrossRefPubMed Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J. 2009;30(4):478–86.CrossRefPubMed
57.
Zurück zum Zitat Crespo-Leiro MG, Anker SD, Maggioni AP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1‑year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613–25.CrossRefPubMed Crespo-Leiro MG, Anker SD, Maggioni AP, et al. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1‑year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613–25.CrossRefPubMed
58.
Zurück zum Zitat Maggioni AP, Anker SD, Dahlström U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173–84.CrossRefPubMed Maggioni AP, Anker SD, Dahlström U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173–84.CrossRefPubMed
59.
Zurück zum Zitat Stock S, Redaelli M, Simic D, Siegel M, Henschel F. Risk factors for the prescription of potentially inappropriate medication (PIM) in the elderly : an analysis of sickness fund routine claims data from Germany. Wien Klin Wochenschr. 2014;126(19–20):604–12.CrossRefPubMed Stock S, Redaelli M, Simic D, Siegel M, Henschel F. Risk factors for the prescription of potentially inappropriate medication (PIM) in the elderly : an analysis of sickness fund routine claims data from Germany. Wien Klin Wochenschr. 2014;126(19–20):604–12.CrossRefPubMed
60.
Zurück zum Zitat Lainscak M, Vitale C, Seferovic P, et al. Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure. Int J Cardiol. 2016;224:191–8.CrossRefPubMed Lainscak M, Vitale C, Seferovic P, et al. Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure. Int J Cardiol. 2016;224:191–8.CrossRefPubMed
61.
Zurück zum Zitat Roblek T, Trobec K, Mrhar A, Lainscak M. Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease. Arch Med Sci. 2014;10(5):920–32.CrossRefPubMedPubMedCentral Roblek T, Trobec K, Mrhar A, Lainscak M. Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease. Arch Med Sci. 2014;10(5):920–32.CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.CrossRefPubMed Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.CrossRefPubMed
63.
Zurück zum Zitat Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014;126(7–8):195–200.CrossRefPubMed Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014;126(7–8):195–200.CrossRefPubMed
64.
Zurück zum Zitat Van Der Wal MHL, Jaarsma T, Van Veldhuisen DJ. Non-compliance in patients with heart failure; How can we manage it? Eur J Heart Fail. 2005;7(1):5–17.CrossRef Van Der Wal MHL, Jaarsma T, Van Veldhuisen DJ. Non-compliance in patients with heart failure; How can we manage it? Eur J Heart Fail. 2005;7(1):5–17.CrossRef
65.
Zurück zum Zitat Mazzella F, Cacciatore F, Galizia G, et al. Social support and long-term mortality in the elderly: role of comorbidity. Arch Gerontol Geriatr. 2010;51(3):323–8.CrossRefPubMed Mazzella F, Cacciatore F, Galizia G, et al. Social support and long-term mortality in the elderly: role of comorbidity. Arch Gerontol Geriatr. 2010;51(3):323–8.CrossRefPubMed
66.
Zurück zum Zitat Tehrani F, Phan A, Chien CV, Morrissey RP, Rafique AM, Schwarz ER. Value of medical therapy in patients 〉80 years of age with heart failure and preserved ejection fraction. Am J Cardiol. 2009;103(6):829–33.CrossRefPubMed Tehrani F, Phan A, Chien CV, Morrissey RP, Rafique AM, Schwarz ER. Value of medical therapy in patients 〉80 years of age with heart failure and preserved ejection fraction. Am J Cardiol. 2009;103(6):829–33.CrossRefPubMed
67.
Zurück zum Zitat Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456–67.CrossRefPubMed Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456–67.CrossRefPubMed
68.
Zurück zum Zitat Lainscak M, Pelliccia F, Rosano G, et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. Int J Cardiol. 2015;200:25–9.CrossRefPubMed Lainscak M, Pelliccia F, Rosano G, et al. Safety profile of mineralocorticoid receptor antagonists: spironolactone and eplerenone. Int J Cardiol. 2015;200:25–9.CrossRefPubMed
69.
Zurück zum Zitat Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging (Milano). 1997;9(6):391–403. Ferrara N, Davia K, Abete P, Rengo F, Harding SE. Alterations in beta-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging (Milano). 1997;9(6):391–403.
70.
Zurück zum Zitat Dungen HD, Musial-Bright L, Inkrot S, et al. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: Insights from the CIBIS-ELD trial. Eur J Heart Fail. 2014;16(8):907–14.CrossRefPubMed Dungen HD, Musial-Bright L, Inkrot S, et al. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: Insights from the CIBIS-ELD trial. Eur J Heart Fail. 2014;16(8):907–14.CrossRefPubMed
71.
Zurück zum Zitat Loncar G, von Haehling S, Tahirovic E, et al. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial. Clin Biochem. 2012;45(1–2):117–22.CrossRefPubMed Loncar G, von Haehling S, Tahirovic E, et al. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial. Clin Biochem. 2012;45(1–2):117–22.CrossRefPubMed
72.
Zurück zum Zitat Lainscak M, Podbregar M, Kovacic D, Rozman J, Von Haehling S. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized trial. Respir Med. 2011;105(Suppl 1):S44–S49.CrossRefPubMed Lainscak M, Podbregar M, Kovacic D, Rozman J, Von Haehling S. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: A randomized trial. Respir Med. 2011;105(Suppl 1):S44–S49.CrossRefPubMed
73.
Zurück zum Zitat Kotecha D, Manzano L, Krum H, et al. Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ. 2016;353:i1855.CrossRefPubMedPubMedCentral Kotecha D, Manzano L, Krum H, et al. Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ. 2016;353:i1855.CrossRefPubMedPubMedCentral
74.
Zurück zum Zitat Tavazzi L, Swedberg K, Komajda M, et al. Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: Insights from the SHIFT study. Eur J Heart Fail. 2013;15(11):1296–303.CrossRefPubMed Tavazzi L, Swedberg K, Komajda M, et al. Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: Insights from the SHIFT study. Eur J Heart Fail. 2013;15(11):1296–303.CrossRefPubMed
75.
Zurück zum Zitat Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med. 2010;170(7):631–7.CrossRefPubMed Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ. Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med. 2010;170(7):631–7.CrossRefPubMed
76.
Zurück zum Zitat Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(16):1500–6.CrossRefPubMed Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(16):1500–6.CrossRefPubMed
77.
Zurück zum Zitat Butler CR, Jugdutt BI. Mechanical circulatory support for elderly heart failure patients. Heart Fail Rev. 2012;17(4–5):663–9.CrossRefPubMed Butler CR, Jugdutt BI. Mechanical circulatory support for elderly heart failure patients. Heart Fail Rev. 2012;17(4–5):663–9.CrossRefPubMed
78.
Zurück zum Zitat McDonagh TA, Blue L, Clark AL, et al. European society of cardiology heart failure association standards for delivering heart failure care. Eur J Heart Fail. 2011;13(3):235–41.CrossRefPubMed McDonagh TA, Blue L, Clark AL, et al. European society of cardiology heart failure association standards for delivering heart failure care. Eur J Heart Fail. 2011;13(3):235–41.CrossRefPubMed
79.
Zurück zum Zitat Maggioni AP, Orso F, Calabria S, et al. The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database. Eur J Heart Fail. 2016;18(4):402–10.CrossRefPubMed Maggioni AP, Orso F, Calabria S, et al. The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database. Eur J Heart Fail. 2016;18(4):402–10.CrossRefPubMed
81.
Zurück zum Zitat Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med. 2011;171(5):384–94.PubMed Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med. 2011;171(5):384–94.PubMed
82.
Zurück zum Zitat SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–16.CrossRef
83.
Zurück zum Zitat Dunbar SB, Clark PC, Quinn C, Gary RA, Kaslow NJ. Family influences on heart failure self-care and outcomes. J Cardiovasc Nurs. 2009;23(3):258–65.CrossRef Dunbar SB, Clark PC, Quinn C, Gary RA, Kaslow NJ. Family influences on heart failure self-care and outcomes. J Cardiovasc Nurs. 2009;23(3):258–65.CrossRef
84.
Zurück zum Zitat Cleland JG, Ekman I. Enlisting the help of the largest health care workforce-patients. JAMA. 2010;304(12):1383–4.CrossRefPubMed Cleland JG, Ekman I. Enlisting the help of the largest health care workforce-patients. JAMA. 2010;304(12):1383–4.CrossRefPubMed
Metadaten
Titel
Heart failure management in the elderly – a public health challenge
verfasst von
Natasa Cvetinovic
Goran Loncar
Jerneja Farkas, MD, PhD
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 7/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1138-y

Weitere Artikel der Sonderheft 7/2016

Wiener klinische Wochenschrift 7/2016 Zur Ausgabe

geriatrics: at crossroads of medicine

Psychocardiology in the elderly

geriatrics: at crossroads of medicine

Frailty and sarcopenia in elderly

geriatrics: at crossroads of medicine

P4 medicine and osteoporosis: a systematic review